Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 24 clinical trials
Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer

Pancreatic adenocarcinoma will be the 2nd cause of death by cancer in Europe in 2030. Pancreatic adenocarcinoma has poor prognosis with an all-stages combined 5-year survival rate below 8%. Since December 2019, a new coronavirus (Severe Acute Respiratory Syndrome Corona Virus 2, SARS-CoV-2) is responsible of COVID-19 infection with potentially …

major surgery
adenocarcinoma
cancer
pancreatic cancer
pancreatic adenocarcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Analysis Of The Anxiety-Depressive Pattern Quality Of Life And Assessment Of Personality in Patients With Pancreatic Ductal Adenocarcinoma (PACT24)

The aim of this study is the evaluation of psychological aspects, such as anxiety-depressive patterns, quality of life, personality and other psychopathological syndromes of patients who receive a diagnosis of pancreatic cancer and who face chemotherapy treatment, radio-chemotherapy or surgery

adenocarcinoma
pancreatic cancer
cancer
ductal adenocarcinoma
pancreatic ductal adenocarcinoma
  • 0 views
  • 05 Aug, 2020
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing diagnosis and treatment at a participating institution. The goals of this project are to build a large database of …

endoscopy
cyst
cancer
intraductal papillary mucinous neoplasms of the pancreas
pancreatitis
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study

The evidence on the value of aspirin, statins, metformin, beta-blocking ACE inhibitors agents as chemopreventive agents in patients with pancreatic ductal adenocarcinoma is limited. The aim of this study is to assess whether regular use of aspirin, statins, metformin, angiotensin converting enzyme (ACE)-inhibitors and beta-blocking agents use, before diagnosis, after …

adenocarcinoma
metformin
chemoradiotherapy
metastasis
adjuvant therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
UCSF Panc Cyst Registry

Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors to pancreatic cancer, and thus pose a substantial risk, however, the vast majority are benign. Increased detection of pancreatic cysts provides an opportunity to …

diabetes
pancreatic cancer
cancer
cyst
  • 0 views
  • 16 Feb, 2024
  • 1 location
The Microbiome of Pancreatic Cancer: "PANDEMIC" Study

Microbiome in patients affected by pancreatic ductal adenocarcinoma may present specific and identifiable patterns. These variations could affect the surgical outcome and increase the risk of life-threatening infections supported by multidrug-resistant bacteria. The identification of microbial signatures with tumor specificity may have a potential role in postoperative risk stratification. Variation …

adenocarcinoma
pancreatic cancer
cancer
breast ductal carcinoma
pancreatic ductal adenocarcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study

The aim of the proposed study is to understand the palliative care needs of patients with pancreatic cancer, to investigate whether early palliative care can improve patient outcomes and reduce use of health care services, and to understand the psychological health of carers and their satisfaction with care.

anxiety
advanced cancer
cancer
palliative care
depression
  • 0 views
  • 16 Feb, 2024
  • 1 location
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer

This is a Norwegian prospective observational study that evaluates the resectability rate in patients with borderline resectable and locally advanced pancreatic cancer who received neoadjuvant chemotherapy in a population based cohort. Eligible patients are treated with neoadjuvant chemotherapy possibly followed by surgical exploration and resection.

folfirinox
adenocarcinoma
pancreatic cancer
cancer
surgical exploration
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Longitudinal Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy

Based on the literature, the pancreatic cancer treatment predictor biomarker, which is used in the domestic clinical field, is actually applied to the pancreatic cancer patient cohort of the National Cancer Center.

cancer
cancer treatment
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of the Life Changes Experienced by Patients With Pancreatic Cancer

The purpose of this study is to better understand what types of transitions people with pancreatic cancer face when they receive chemotherapy. Again, this study defines transition as a change in a life situation or a status that causes a change in a person's identity, role, behavior, or personal relationships.

cancer chemotherapy
cancer
anxiety
  • 0 views
  • 05 Aug, 2020